AN2 Therapeutics Inc Long-term Investment Intensity
AN2 Therapeutics Inc long-term investment intensity. AN2 Therapeutics Inc (ANTX) has a Long-term Investment Intensity of 1.8% as of June 2026. Long-term investments of $1.47 Million represent 1.8% of total assets of $81.68 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read debt load of AN2 Therapeutics Inc for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of AN2 Therapeutics Inc (2021–2025)
Long-term investment intensity of AN2 Therapeutics Inc from 2021 to 2025. This chart shows how AN2 Therapeutics Inc's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the intensity stands at 1.8%, reflecting long-term investments of $1.47 Million against total assets of $81.68 Million USD.
AN2 Therapeutics Inc Long-term Investment Intensity by Year (2021–2025)
AN2 Therapeutics Inc long-term investment intensity by year from 2021 to 2025. The table below presents the year-by-year Long-term Investment Intensity for AN2 Therapeutics Inc from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see ANTX asset base.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 3.2% | $2.01 Million | $61.95 Million | ▼ -2.2 pp |
| 2024 | 5.5% | $5.02 Million | $92.09 Million | ▼ -14.1 pp |
| 2023 | 19.6% | $27.19 Million | $138.74 Million | ▲ +16.5 pp |
| 2022 | 3.1% | $3.22 Million | $102.56 Million | ▼ -2.2 pp |
| 2021 | 5.3% | $3.49 Million | $65.32 Million | — |